Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Dec 31:pvaa138. doi: 10.1093/ehjcvp/pvaa138

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2021. For permissions, please email: journals.permissions@oup.com.

This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections.

This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model)

PMC Copyright notice

Likelihood of positive SARS-CoV-2 test in patients with history of hypertension who were tested. Random effects meta-analysis. ACEi, angiotensin-converting enzyme inhibitor; ARB, angiotensin-receptor blocker; SARS-CoV-2, severe acute respiratory syndrome-coronavirus-2; USA, United States of America. All studies were published in the year 2020. Dauchet (ACEi/ARB numbers manually calculated with assumption that no patients used ACEi and ARB at the same time). Mehta (includes previously unpublished data from authors).